Comment on "Inflawell, neutrophil-to-lymphocyte ratio and COVID-19"
- PMID: 35316428
- PMCID: PMC8938649
- DOI: 10.1007/s10787-022-00970-8
Comment on "Inflawell, neutrophil-to-lymphocyte ratio and COVID-19"
Keywords: COVID-1; Inflawell; Neutrophil-to-lymphocyte ratio.
Conflict of interest statement
The authors are from poor developing country and cannot pay for any charge and ask for full waiving for this correspondence letter.
Comment on
-
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.Inflammopharmacology. 2022 Apr;30(2):465-475. doi: 10.1007/s10787-022-00928-w. Epub 2022 Feb 24. Inflammopharmacology. 2022. PMID: 35201518 Free PMC article. Clinical Trial.
References
-
- Barzin Tond S, Balenci L, Khajavirad N, Salehi M, Tafakhori A, Shahmohammadi MR, Ghiasvand F, Jafari S, Abolghasemi S, Mokhtari F, Mahmoodi Baram S, Zarei T, Kazemi D, Mohammadnejad E, Shah-Hosseini A, Haghbin Toutounchi A, Fallah S, Riazi A, Karima S. Inflawell() improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial. Inflammopharmacology. 2022 doi: 10.1007/s10787-022-00928-w. - DOI - PMC - PubMed
-
- Health Devices Miles Technicon H.2 automated hematology analyzer. Health Devices. 1992;21:387–419. - PubMed
-
- Takubo T, Tatsumi N, Satoh N, Matsuno K, Fujimoto K, Soga M, Yamagami Y, Akiba S, Sudoh T, Miyazaki M. Evaluation of hematological values obtained with reference automated hematology analyzers of six manufacturers. Southeast Asian J Trop Med Public Health. 2002;33(Suppl 2):62–67. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical